|
| 治疗组 |
整体 |
RGI |
NRGI |
|
| 体积膨胀/氟氢可的松 |
23/76 (30%) |
15/32 (47%) |
8/44 (18%) |
| 三环抗抑郁药 |
9/76 (12%) |
6/32 (19%) |
3/44 (7%) |
| β受体阻断剂 |
25/76 (32%) |
10/32 (31%) |
15/44 (34%) |
| 赛庚啶 |
3/76 (4%) |
2/32 (6%) |
1/44 (2%) |
| 选择性血清再吸收抑制剂 |
18/76 (23%) |
10/32 (31%) |
8/44 (18%) |
| 抗癫痫 |
5/76 (6%) |
2/32 (6%) |
3/44 (7%) |
| Proamatine |
9/76 (12%) |
5/32 (16%) |
4/44 (9%) |
| 加巴喷丁 |
2/76 (2%) |
1/32 (3%) |
1/44 (2%) |
| Mestinon |
1/76 (1%) |
1/32 (3%) |
0/44 (0%) |
| 没有治疗 |
17/76 (22%) |
3/32 (9%) |
14/44 (31%) |
|
|
